Katherine C. Doyle, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 10,682 shares at $39.02 ($420K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($420k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.79 | 4,043 | $161K | 38.3% |
| 2 | $39.00 | 1,651 | $64K | 15.3% |
| 3 | $39.01 | 900 | $35K | 8.4% |
| 4 | $39.01 | 3,888 | $152K | 36.1% |
| 5 | $39.02 | 200 | $8K | 1.9% |
| Total | $39.30 avg | 10,682 |
| $420K |
| 100% |
| Filing → |
| ABT | SELL | 2015-03-13 | $412 | — | Filing → |